-
A selfie and a smartphone app could help diagnose pancreatic cancer early
fiercebiotech
August 31, 2017
BilliScreen uses machine learning algorithms to measure the amount of bilirubin in a person's eyes from a photo.
-
Nitrogen-clearing enzyme a new target for difficult-to-treat pancreatic cancers
fiercebiotech
August 22, 2017
Pancreatic cancer is difficult to treat because of the organ's location deep in the body. Attacking tumor metabolism is one way to get around this hurdle.
-
A one-two punch hits pancreatic cancer where it hurts
worldpharmanews
April 10, 2017
Australian scientists have uncovered a promising new approach to treating pancreatic cancer, by targeting the tissue around the tumour to make it 'softer' and more responsive to chemotherapy.
-
NICE does not recommend Shire’s pancreatic cancer drug
europeanpharmaceuticalreview
April 05, 2017
The National Institute or Health and Care Excellence (NICE) has published final guidance that does not recommend pegylated liposomal irinotecan (Onivyde, Shire).
-
Cancer Research UK announces £10m pancreatic cancer project
pharmafile
March 27, 2017
Cancer Research UK has revealed a £10 million investment into PRECISION-Panc, a pancreatic cancer-focused project which aims to improve patient survival rates by accelerating scientific discovery and utilising precision medicine approaches.
-
ChemoCentryx Announces Presentation of Data from Ongoing Phase Ib Clinical Trial of CCR2 Inhibitor C
firstwordpharma
January 22, 2017
ChemoCentryx, Inc., announced the presentation of results from its immuno-oncology program at the American Society of Clinical Oncology (ASCO) 2017 Gastrointestinal Cancers Symposium being held January 19-21, 2017 in San Francisco, California.